Bicycle
Manufacturing · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Blocks a & B Portway Building Granta Gre...Phone Number
+44 1223261503Website
www.bicycletherapeutics.comRevenue
$63.5 MillionStock Symbol
BCYCIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1
About Bicycle
Bicycle Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of medicines based on bicyclic peptides. Using innovative science, it develops fully synthetic molecules designed for high target specificity and binding affinity. The company is advancing therapies for cancer and other diseases, including tumor-targeted and immune-activating treatments, as well as radiopharmaceutical applications, while exploring broader therapeutic opportunities through strategic partnerships.Explore more
Bicycle Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bicycle your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Bicycle recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bicycle has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Bicycle is spiking on competitors!
Click to see if Bicycle had a recent Job posting/layoffs
Product Launch: Get notified when Bicycle launches new products
Bicycle, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bicycle
Funding: Get notified immidiatlly once Bicycle has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Bicycle
Compare insights from companies similar to Bicycle, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bicycle is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bicycle is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bicycle.
Bicycle financials insights
Gather financial insights about Bicycle, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$50M
Debt
$40M
2024
Share Placement
$555M
Bicycle Tech Stack
A closer look at the technologies used by Bicycle
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Promotion
Executive Move
Jennifer Perry has recently been promoted from Chief Strategy Officer & Head of Commercial to the role of Chief Operating Officer.
Executive Moves, Promotion
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Bicycle News & Media
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
Bicycle Therapeutics plc (NASDAQ:BCYC) is one of the 7 Fastest Growing European Stocks to Invest In. On March 18, 2026, RBC Capital lowered the price target on Bicycle Therapeutics plc (NASDAQ:BCYC) to $7 from $11 and maintained a Sector Perform rating, citing the company’s pivot away from zelenectide as a near-term setback that reduces visibility […]Bicycle Therapeutics (BCYC) Appoints Travis Thompson as CFO Following Leadership Transitions
Bicycle Therapeutics (NASDAQ:BCYC) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 3, Bicycle Therapeutics announced several key leadership transitions as the company enters a new phase of innovation for its proprietary bicyclic peptide technology. Travis Thompson, who joined the firm in 2018 and previously served as senior vice […]Bicycle Therapeutics names new CFO, CMO, CSO | BCYC Stock News
New CFO, CMO and CSO take over finance, clinical development and research at Bicycle Therapeutics, as the company cites a cash runway into 2028.Analysts Positive on Bicycle Therapeutics (BCYC) After Q2 Results
Bicycle Therapeutics plc (NASDAQ:BCYC) is one of the Top 10 Stocks Under $10 That Could Triple. On August 11, RBC Capital increased its price target on Bicycle Therapeutics plc (NASDAQ:BCYC) from $25 to $27 and kept an Outperform rating after the company reported its Q2 2025 results. The research firm pointed out that the update […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bicycle
Sign Up For FreeTo access detailed company insights
Bicycle Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of medicines based on bicyclic peptides. Using innovative science, it develops fully synthetic molecules designed for high target specificity and binding affinity. The company is advancing therapies for cancer and other diseases, including tumor-targeted and i... Read More
